SCM
IDYA icon

Superstring Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Superstring Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-227,102
Closed -$5.84M – 40
2024
Q4 		$5.84M Buy
+227,102
New +$6.43M 5.05% 9
2024
Q2 		– Sell
-217,070
Closed -$9.53M – 47
2024
Q1 		$9.53M Sell
217,070
-34,225
-14% -$1.47M 6.3% 6
2023
Q4 		$8.94M Buy
+251,295
New +$7.5M 6.38% 5

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Superstring Capital Management's IDYA Position: Q1 2025 in Review

Superstring Capital Management sold out of IDEAYA Biosciences (IDYA) in Q1 2025, closing a stake of 227,102 shares — an estimated $5.84M sold.

Superstring Capital Management first reported a position in IDYA in Q4 2023 and held it in 3 quarters. The position peaked at $9.53M in Q1 2024. 207 funds tracked by Wall St. Rank hold IDYA as of Q1 2025.

  • Superstring Capital Management reported no remaining IDEAYA Biosciences position as of Q1 2025 after selling out during the quarter.
  • Superstring Capital Management sold 227,102 IDEAYA Biosciences shares in Q1 2025, an estimated $5.84M.
  • Superstring Capital Management first reported a position in IDEAYA Biosciences in Q4 2023 and held it in 3 quarters.
  • Superstring Capital Management's IDEAYA Biosciences position peaked at $9.53M in Q1 2024.
  • 207 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2025.

Based on Superstring Capital Management's 13F filing for Q1 2025, filed 15 May 2025.